Links

Tools

Export citation

Search in Google Scholar

Parathyroid hyperplasia in Primary and Secondary Hyperparathyroidism

Journal article published in 1994 by G. Favia, F. Lumachi, P. Carraro ORCID, D. F. D'Amico
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

Background: Different opinions exist on the surgical treatment in primary (pHPT) and secondary (sHPT) hyperparathyroidism due to parathyroid hyperplasia, i.e. subtotal parathyroidectomy (SPTx) v/s total parathyroidectomy and autotransplantation (TPTx). We analyse the advantages and disadvantages obtained by these different treatments. Methods: From 1977 to 1991, 219 patients with primary HPT (199 pts) and secondary HPT (20 pts) underwent parathyroid exploration. Of the patients with pHPT, 31 (15.6%) had parathyroid hyperplasia; of these, 27 underwent SPTx and 4 TPTx. In patients with sHPT we performed 15 SPTx and 5 TPTx. Results: At 5-18 months follow-up, 26 (83.9%) patients with pHPT have become normocalcemic, 3 (SPTx) have been operated on for persistent or recurrent HPT and 2 (SPTx) are hypocalcemic. Three years after operation, 11 out of 15 patients treated by SPTx for sHPT and 4 out of 5 pts treated by TPTx showed a significant improvement in the clinical and radiological picture of disease, 5 and 10 years respectively after TPTx 2 out of 5 patients underwent excision of the implant. Conclusions: TPTx is the treatment of choice in pHPT patients, whereas in sHPT we prefer SPTx if the patient cannot subsequently undergo a renal transplant.